Schizophrenia 19 Aug, 2024

Impact of cognitive and positive symptoms on treatment choice in schizophrenia

Professors Gin Malhi and Gregory Mattingly examine cognitive and positive symptoms, why they matter, and how they impact treatment choice in schizophrenia.

The views and opinions expressed in this video do not necessarily reflect those of Lundbeck and Otsuka.

Page: AU-ABIM-0586. September 2024. Video: AU-ABIM-0527. March 2024.

Topics

  • Schizophrenia

Contributors

Professor Gin Malhi
Psychiatric Chair, University of Sydney
Dr Gregory Mattingly
MD, Associate Professor Washington University School of Medicine and President, Midwest Group, St. Louis, Missouri, USA

BROUGHT TO YOU BY

Lundbeck
© 2022 Lundbeck Australia

PROGRESS IN MIND AUSTRALIA

Lundbeck and Privacy

Cookies

Lundbeck Australia Pty Ltd
1 Innovation Road, Ground floor
NSW 2113, North Ryde, Australia
Phone +61 2 8669 1000
Fax +61 2 8669 1090

subscribe newsletter

Sign up for newsletter

This website is intended for viewing only by health care professionals in Australia.

All information provided within this site is intended only for residents of Australia.